Back to search

Virginia Tech

Breadth of Protection: Evaluating Long‑Term Immunogenicity, Cross‑Protection, and Dissemination Strategies of the ARPV/ZIKV Vaccine

Abstract

dc:description.abstract

Zika virus (ZIKV) is a mosquito-borne Orthoflavivirus that is distributed throughout the Americas, Africa, and Asia. Zika virus has also been known to co-circulate with other Orthoflaviviruses such as West Nile, Dengue, Japanese encephalitis virus, and yellow fever virus. Our central goal is to produce a robust immunogenic vaccine against ZIKV. ARPV/ZIKV (Aripo-Zika) is a chimeric virus containing the prM and E proteins of ZIKV and the nonstructural proteins of Aripo virus (ARPV). Herein, we explore ARPV/ZIKV cross-protection against other Orthoflaviviruses, durability of protection and best dissemination strategies. Immune competent and immune compromised mice were vaccinated with ARPV/ZIKV and challenged with SPOV. Our data indicates SPOV is cross-protective against SPOV in both mouse models, but does not completely protect against all symptoms of disease. We also assessed the durability of protection afforded by ARPV/ZIKV in immune competent mice over ten months and assessed the best dissemination strategies for delivering the vaccine. Our results indicate ARPV/ZIKV completely protects against a ZIKV challenge ten months post vaccination. Also, ARPV/ZIKV was not compatible with Sf9 cells, which have been used for propagation of other vaccines; and the strategies used to lyophilize ARPV/ZIKV did not produce a uniform stable powder product. However, we did determine that ARPV/ZIKV can be concentrated and stored long-term for vaccine research and transport. Overall, our data indicate the chimeric vaccine platform continues to be a promising avenue for developing a vaccine for ZIKV and other Orthoflaviviruses.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy
Level thesis:degree_level
doctoral
Discipline thesis:degree_discipline
Entomology
Department dc:contributor.department
Entomology
Grantor dc:publisher
Virginia Tech
Year dc:date.issued
2026

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Tanelus, Manette
Chair dc:contributor.committeechair
  • Auguste, Albert Jonathan
Committee members dc:contributor.committeemember
  • Allen, Irving Coy
  • Caswell, Clayton C.
  • Bertke, Andrea S.
  • Paulson, Sally L.

Subjects

dc:subject × 5

Rights

dc:rights
Statement dc:rights
  • In Copyright
Language dc:language.iso
en

Identifiers

dc:identifier.*
Dc Identifier Other
vt_gsexam:46764

Chain of custody

source
Harvested from
Virginia Tech
Base URL
vtechworks.lib.vt.edu/oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Tanelus, Manette. Breadth of Protection: Evaluating Long‑Term Immunogenicity, Cross‑Protection, and Dissemination Strategies of the ARPV/ZIKV Vaccine. doctoral thesis, Virginia Tech, 2026. https://hdl.handle.net/10919/143418